{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9NZJ5",
      "entity_text" : "pERK",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-1001" ],
      "CellType" : [ "cl:CL:0000084" ],
      "Species" : [ "taxonomy:10090" ]
    }
  },
  "verbose_text" : "Furthermore, pulsatile treatment with selumetinib results in the maintenance of a higher level of pERK in both CD8+ and CD4+ T cells, compared to continuous treatment (XREF_SUPPLEMENTARY), suggesting reduced suppression of MEK signaling pathways by pulsatile treatment in T cells.",
  "reading_complete" : "2020-08-08T10:51:41Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T10:49:20Z",
  "trigger" : "level",
  "evidence" : [ "level of pERK" ],
  "pmc_id" : "6719696",
  "score" : 0
}